1. Home
  2. DY vs ARWR Comparison

DY vs ARWR Comparison

Compare DY & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dycom Industries Inc.

DY

Dycom Industries Inc.

HOLD

Current Price

$483.26

Market Cap

12.3B

Sector

Industrials

ML Signal

HOLD

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

HOLD

Current Price

$79.81

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DY
ARWR
Founded
1969
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.3B
10.2B
IPO Year
1995
2009

Fundamental Metrics

Financial Performance
Metric
DY
ARWR
Price
$483.26
$79.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
10
Target Price
$425.30
$83.40
AVG Volume (30 Days)
602.0K
1.5M
Earning Date
05-20-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
20.71
99.80
EPS
3.00
N/A
Revenue
N/A
$16,142,321.00
Revenue This Year
$30.96
N/A
Revenue Next Year
$9.49
N/A
P/E Ratio
$154.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$233.00
$14.30
52 Week High
$566.47
$84.55

Technical Indicators

Market Signals
Indicator
DY
ARWR
Relative Strength Index (RSI) 58.23 57.26
Support Level $335.20 $70.05
Resistance Level $490.00 $82.26
Average True Range (ATR) 22.75 3.83
MACD -1.78 0.55
Stochastic Oscillator 82.61 68.16

Price Performance

Historical Comparison
DY
ARWR

About DY Dycom Industries Inc.

Dycom Industries Inc is a provider of specialty contracting services to the telecommunications infrastructure and utility industries throughout the United States. The company has two reporting segments: Communications and Building Systems. The Communications segment provides specialty contracting services, including program management, planning; engineering and design; aerial, underground, and wireless construction; maintenance; and fulfillment services for telecommunications and digital infrastructure providers. The Building Systems segment specializes in providing comprehensive building infrastructure solutions, including electrical, energy management, security, and fire safety systems for data centers and other critical facilities. The firm generates key revenue from Communications.

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

Share on Social Networks: